Atlas Trials

Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion

Clinical trial NCT05625893 · COMPLETED

Trial details

NCT number
NCT05625893
Sponsor
Samsung Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular CarcinomaPortal Vein Thrombosis
Start date
2023-01-15
Primary completion
2025-11-30
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.